Rajpoot M, Singh D, Pandey K, Bhargava R. Safety and efficacy of cyclosporine (0.05% versus 0.09%) in dry eye disease. Is it the strength of cyclosporin that really matters? . Nep J Oph [Internet]. 2022 Dec. 31 [cited 2024 Dec. 26];14(2):64-77. Available from: https://nepjol.info./index.php/NEPJOPH/article/view/38928